Company Results for 1 April 2021
-
01 Apr
08:51Syncona portfolio company Freeline posts $29.1m rise in R&D costs in 2020Healthcare investor Syncona has reported that portfolio company Freeline Therapeutics booked higher research and development expenses in 2020 and confirmed its plans to have three AAV gene therapy...
-
01 Apr
07:28Next sees full price sales decline 15%; raises profit guidance to £700m after stronger-than-expected online salesClothing retailer Next has posted a 15% fall in full price sales and pre-tax profit in line with guidance as most of its stores remained closed for a 'significant portion' of 2020/21 and forecast...